The company
Eisai is a global leading research-based pharmaceutical company driven by “giving first thought to patients and their families and increasing the benefits that health care provides”. Eisai is committed to research and development and has an exciting pipeline from new discoveries, acquired molecules and further development of licensed products within Neurology, Gastroenterology, Critical Care and Oncology. With operations in U.S., Asia, Europe and the domestic market of Japan, Eisai employs 11.000 people worldwide. The Nordic headquarter is in Sweden, Danderyd, north of Stockholm.
Further information about the company in Europe can be found on http://www.eisai.co.uk.
About Oncology
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma. Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor (combination studies for several indications in collaboration with Merck & Co/MSD. Lenvima (lenvatinab) + Keytruda (pembrolizumab)). In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
About Neurology
Eisai has a unique position in Epilepsy with four products on the market. The company has a very interesting pipeline and is fully committed to maintaining a long-term position in the area of Neurology.
Eisai is a global leading research-based pharmaceutical company driven by “giving first thought to patients and their families and increasing the benefits that health care provides”. Eisai is committed to research and development and has an exciting pipeline from new discoveries, acquired molecules and further development of licensed products within Neurology, Gastroenterology, Critical Care and Oncology. With operations in U.S., Asia, Europe and the domestic market of Japan, Eisai employs 11.000 people worldwide. The Nordic headquarter is in Sweden, Danderyd, north of Stockholm.
Further information about the company in Europe can be found on http://www.eisai.co.uk.
About Oncology
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma. Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor (combination studies for several indications in collaboration with Merck & Co/MSD. Lenvima (lenvatinab) + Keytruda (pembrolizumab)). In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
About Neurology
Eisai has a unique position in Epilepsy with four products on the market. The company has a very interesting pipeline and is fully committed to maintaining a long-term position in the area of Neurology.
TILLSATT - Medical Manager Oncology Nordics, Eisai
Exciting opportunity for a talented Medical Manager
The position – Medical Manager Oncology Nordics
Job title: Medical Manager, Oncology Business Group (OBG), Eisai Nordics
Employment Type: Full-time
Department: EMEA Oncology Business Group
Report to position: Medical Director, Nordics (location Stockholm)
Location: Field-based Norway, Denmark, Sweden
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma.
Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor (combination studies for several indications in collaboration with Merck & Co/MSD). In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
We are looking for an experienced professional with a successful performance in a scientific communication role/medical affairs role in the area of Oncology with previous experience working with medical strategies.�
Main purpose of the job
1) Close collaboration with Medical Director, MSL, Marketing, Sales and Market Access team to jointly produce and execute strategic plans for current and future indications within current portfolio
2) Manage, coach and engage Nordic OBG MSL/s
3) Exchange of scientific data and sharing clinical information with internal stakeholders in the Nordics and the EMEA team as well as with external stakeholders
4) Establish solid relationships among regional KOLs and other key stakeholders
5) You will engage in the exchange of scientific data and sharing clinical information on a peer-to-peer basis
6) Alignment with Nordic Medical Director for key governance requirements.
Opportunities with the role
Eisai is a growing company worldwide and even more so in the Nordic and European region. In the expansion and development of the company, Eisai maintains full focus on the hhc philosophy (human health care), which means a full commitment to deliver health to patients and their families. This is reflected in the spirit and the positive culture that you find among Eisai employees. Eisai encourages employees to engage and spend time with patients to be able to truly understand patients’ situations and simply do good for patients.
Eisai is a dynamic company with short decision lines and a broad-based responsibility for every individual employee. That means an opportunity to influence and take initiatives that will add value to patients, healthcare and the society.
Eisai has developed and built a solid platform for growth within Oncology. The product portfolio and pipeline are innovative and there will be several important launches the coming years.
The MM role is broad-based role combining strategic leadership and operations in close collaboration with Healthcare. The MM will be a key player for the future development and success of the Oncology business in the Nordics.
The right candidate will be part of an experienced and professional team with a great spirit. The MM will receive support and development from the Nordic management and from the Europe North team in London.
Eisai offers continues development for all personnel, both individual and team oriented. An individual development plan will be agreed with the line manager.
Qualifications and education required
• Bachelor’s degree in pharmacy, Pharmacology or Bio-medical sciences. PhD or Medical degree is advantageous
• Oncology experience essential
• Intimate knowledge of regional therapy infrastructure including key opinion leaders, major centres, market access and other related activities
• Adequate clinical knowledge is essential
• Extended experience in industry is mandatory
• Experience working with strategic questions
• Experience from a management position is an advantage (or motivated and skilled to take on a leadership assignment)
• Some experience of clinical development, clinical operations, biostatistics, safety and regulatory affairs is desirable.
Key competencies and skills
• Team player. Comfortable working in matrix environment, closely with commercial department
• Flair for creativity, new ideas and solutions
• Fast learner – You will be able to familiarise yourself with new therapeutic areas and compounds quickly
• Excellent communication skills. You will be comfortable conversing with the leading experts in any given field of medicine
• Eye for detail. Able to do the “head’s down” work in addition to the other requirements. Competent in critical appraisal of data & evidence-based medicine
• Possess a strong sense of responsibility and have a good track record of working independently and meeting strict deadlines
• Flexibility, adaptability. Proactive
• Diplomatic. Able to deal with a range of personalities to achieve objectives.
Language skills and other
Fluent in English and at least one Scandinavian language. Good understanding and ability to communicate in other Nordic countries.
Advanced computer skills (Microsoft Word, PowerPoint, Excel, Project).
Clean and valid driver’s licence.
Contact
For inquires and more information about the Medical Manager Oncology Nordics position, please contact Magnus Klingberg or Sara Steinvall, Senior Recruitment Consultants at PeakSearch.
Apply for the position at http://www.peaksearch.se.
Contact details
Magnus Klingberg
Magnus.klingberg@peaksearch.se, +46-70 678 09 92, +46-8 545 00 100
Sara Steinvall
sara.steinvall@peaksearch.se. +46-70 204 37 42, +46-8 545 00 100
Job title: Medical Manager, Oncology Business Group (OBG), Eisai Nordics
Employment Type: Full-time
Department: EMEA Oncology Business Group
Report to position: Medical Director, Nordics (location Stockholm)
Location: Field-based Norway, Denmark, Sweden
Eisai has a pipeline of products in development for treating cancer and has a strong focus to establish a long-term position in the area of Oncology. The company is now 9 years into launching their first product in the area of Oncology and has two products on the market; Halaven™ (eribulin) is a first-in-class treatment for advanced or metastatic breast cancer and Lenvima multi-targeted receptor tyrosine kinase inhibitor for thyroid cancer, kidney cancer and hepatocellar Carcinoma.
Eisai has a very interesting future pipeline in Oncology. Halaven and Lenvima are being explored in several other tumour areas as single agent therapy as well as in combination, including studies with PD1 inhibitor (combination studies for several indications in collaboration with Merck & Co/MSD). In earlier development several compounds including immunotherapies, monoclonal antibodies, small peptides.
We are looking for an experienced professional with a successful performance in a scientific communication role/medical affairs role in the area of Oncology with previous experience working with medical strategies.�
Main purpose of the job
1) Close collaboration with Medical Director, MSL, Marketing, Sales and Market Access team to jointly produce and execute strategic plans for current and future indications within current portfolio
2) Manage, coach and engage Nordic OBG MSL/s
3) Exchange of scientific data and sharing clinical information with internal stakeholders in the Nordics and the EMEA team as well as with external stakeholders
4) Establish solid relationships among regional KOLs and other key stakeholders
5) You will engage in the exchange of scientific data and sharing clinical information on a peer-to-peer basis
6) Alignment with Nordic Medical Director for key governance requirements.
Opportunities with the role
Eisai is a growing company worldwide and even more so in the Nordic and European region. In the expansion and development of the company, Eisai maintains full focus on the hhc philosophy (human health care), which means a full commitment to deliver health to patients and their families. This is reflected in the spirit and the positive culture that you find among Eisai employees. Eisai encourages employees to engage and spend time with patients to be able to truly understand patients’ situations and simply do good for patients.
Eisai is a dynamic company with short decision lines and a broad-based responsibility for every individual employee. That means an opportunity to influence and take initiatives that will add value to patients, healthcare and the society.
Eisai has developed and built a solid platform for growth within Oncology. The product portfolio and pipeline are innovative and there will be several important launches the coming years.
The MM role is broad-based role combining strategic leadership and operations in close collaboration with Healthcare. The MM will be a key player for the future development and success of the Oncology business in the Nordics.
The right candidate will be part of an experienced and professional team with a great spirit. The MM will receive support and development from the Nordic management and from the Europe North team in London.
Eisai offers continues development for all personnel, both individual and team oriented. An individual development plan will be agreed with the line manager.
Qualifications and education required
• Bachelor’s degree in pharmacy, Pharmacology or Bio-medical sciences. PhD or Medical degree is advantageous
• Oncology experience essential
• Intimate knowledge of regional therapy infrastructure including key opinion leaders, major centres, market access and other related activities
• Adequate clinical knowledge is essential
• Extended experience in industry is mandatory
• Experience working with strategic questions
• Experience from a management position is an advantage (or motivated and skilled to take on a leadership assignment)
• Some experience of clinical development, clinical operations, biostatistics, safety and regulatory affairs is desirable.
Key competencies and skills
• Team player. Comfortable working in matrix environment, closely with commercial department
• Flair for creativity, new ideas and solutions
• Fast learner – You will be able to familiarise yourself with new therapeutic areas and compounds quickly
• Excellent communication skills. You will be comfortable conversing with the leading experts in any given field of medicine
• Eye for detail. Able to do the “head’s down” work in addition to the other requirements. Competent in critical appraisal of data & evidence-based medicine
• Possess a strong sense of responsibility and have a good track record of working independently and meeting strict deadlines
• Flexibility, adaptability. Proactive
• Diplomatic. Able to deal with a range of personalities to achieve objectives.
Language skills and other
Fluent in English and at least one Scandinavian language. Good understanding and ability to communicate in other Nordic countries.
Advanced computer skills (Microsoft Word, PowerPoint, Excel, Project).
Clean and valid driver’s licence.
Contact
For inquires and more information about the Medical Manager Oncology Nordics position, please contact Magnus Klingberg or Sara Steinvall, Senior Recruitment Consultants at PeakSearch.
Apply for the position at http://www.peaksearch.se.
Contact details
Magnus Klingberg
Magnus.klingberg@peaksearch.se, +46-70 678 09 92, +46-8 545 00 100
Sara Steinvall
sara.steinvall@peaksearch.se. +46-70 204 37 42, +46-8 545 00 100